Syk tyrosine kinase inhibitors (InKine)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSyk tyrosine kinase inhibitors (InKine)
Drug Alias NameASO (Inkine)Syk AS ODNSyk antisense oligonucleotideantisense oligonucleotides (InKine)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsInflammationHypersensitivityAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInkine Pharmaceutical
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityAutoimmune Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A